ASH 2022: Promising Results in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma

Press/Media

Period	4 Jan 2023

Media coverage

Title	ASH 2022: Promising Results in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma
Media name/outlet	Cancer Therapy Advisor
Country/Territory	United States
Date	4/01/23
URL	ct.moreover.com/?a=49668033443&p=1gw&v=1&x=_K7RuT9pAVB9eFBByOWlSg
Persons	Ajai Chari